Laboratory and testing services
Ended Purchase Order Awarded Last action
- Contract number
- 75N91021P00554
- Awardee
-
Abterra Biosciences, Inc. UEI TYHDLNB65NJ1
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $15,000
Award facts
- Contract value 100% obligated
- $15,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- San Diego, CA 92109, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Vendor DUNS or Name Change - Non-Novation | $0 | |
| Original award | $15,000 |
About this award
The National Cancer Institute awarded a $15,000 purchase order to Abterra Biosciences, Inc. for laboratory and testing services, effective June 25, 2021, with completion by June 23, 2022. Work is performed in San Diego, California. The order is firm fixed price with no small business set-aside applied.
Quick answers
Who was awarded contract 75N91021P00554?
75N91021P00554 was awarded to Abterra Biosciences, Inc. by National Cancer Institute (National Institutes of Health) on June 25, 2021.
How much is contract 75N91021P00554 worth?
The government has obligated $15,000 on 75N91021P00554.
Was contract 75N91021P00554 competed?
The extent of competition for 75N91021P00554 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award